BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24239359)

  • 1. Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells.
    Blum JM; Añó L; Li Z; Van Mater D; Bennett BD; Sachdeva M; Lagutina I; Zhang M; Mito JK; Dodd LG; Cardona DM; Dodd RD; Williams N; Ma Y; Lepper C; Linardic CM; Mukherjee S; Grosveld GC; Fan CM; Kirsch DG
    Cell Rep; 2013 Nov; 5(4):933-40. PubMed ID: 24239359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
    Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
    Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.
    Hsu JY; Danis EP; Nance S; O'Brien JH; Gustafson AL; Wessells VM; Goodspeed AE; Talbot JC; Amacher SL; Jedlicka P; Black JC; Costello JC; Durbin AD; Artinger KB; Ford HL
    Cell Rep; 2022 Feb; 38(5):110323. PubMed ID: 35108532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor-Significance of Tumor Subclones.
    Skrzypek K; Adamek G; Kot M; Badyra B; Majka M
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic essentiality between PTEN and core dependency factor PAX7 dictates rhabdomyosarcoma identity.
    Langdon CG; Gadek KE; Garcia MR; Evans MK; Reed KB; Bush M; Hanna JA; Drummond CJ; Maguire MC; Leavey PJ; Finkelstein D; Jin H; Schreiner PA; Rehg JE; Hatley ME
    Nat Commun; 2021 Sep; 12(1):5520. PubMed ID: 34535684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p16/Ink4a drives high frequency of rhabdomyosarcoma in a rat model of Duchenne muscular dystrophy.
    Teramoto N; Ikeda M; Sugihara H; Shiga T; Matsuwaki T; Nishihara M; Uchida K; Yamanouchi K
    J Vet Med Sci; 2021 Sep; 83(9):1416-1424. PubMed ID: 34334511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWIST2-mediated chromatin remodeling promotes fusion-negative rhabdomyosarcoma.
    Shah AM; Guo L; Morales MG; Jaichander P; Chen K; Huang H; Cano Hernandez K; Xu L; Bassel-Duby R; Olson EN; Liu N
    Sci Adv; 2023 Apr; 9(17):eade8184. PubMed ID: 37115930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma.
    Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ
    J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53.
    Saito H; Suzuki N
    Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining the Extracellular Matrix of Rhabdomyosarcoma.
    Lian X; Bond JS; Bharathy N; Boudko SP; Pokidysheva E; Shern JF; Lathara M; Sasaki T; Settelmeyer T; Cleary MM; Bajwa A; Srinivasa G; Hartley CP; Bächinger HP; Mansoor A; Gultekin SH; Berlow NE; Keller C
    Front Oncol; 2021; 11():601957. PubMed ID: 33708626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse genetic background influences whether
    Brandt LP; Albers J; Hejhal T; Pfundstein S; Gonçalves AF; Catalano A; Wild PJ; Frew IJ
    Oncotarget; 2018 Apr; 9(28):19753-19766. PubMed ID: 29731980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental Heterogeneity of Rhabdomyosarcoma.
    Stevens BT; Hatley ME
    Cold Spring Harb Perspect Med; 2024 May; ():. PubMed ID: 38772705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to generate genetically engineered mouse models of soft tissue sarcoma.
    Dodd RD; Añó L; Blum JM; Li Z; Van Mater D; Kirsch DG
    Methods Mol Biol; 2015; 1267():283-95. PubMed ID: 25636474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.
    Sachdeva M; Mito JK; Lee CL; Zhang M; Li Z; Dodd RD; Cason D; Luo L; Ma Y; Van Mater D; Gladdy R; Lev DC; Cardona DM; Kirsch DG
    J Clin Invest; 2014 Oct; 124(10):4305-19. PubMed ID: 25180607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into signalling-pathway alterations in rhabdomyosarcoma.
    Zhu B; Davie JK
    Br J Cancer; 2015 Jan; 112(2):227-31. PubMed ID: 25211658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation.
    Tremblay AM; Missiaglia E; Galli GG; Hettmer S; Urcia R; Carrara M; Judson RN; Thway K; Nadal G; Selfe JL; Murray G; Calogero RA; De Bari C; Zammit PS; Delorenzi M; Wagers AJ; Shipley J; Wackerhage H; Camargo FD
    Cancer Cell; 2014 Aug; 26(2):273-87. PubMed ID: 25087979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute tissue injury activates satellite cells and promotes sarcoma formation via the HGF/c-MET signaling pathway.
    Van Mater D; Añó L; Blum JM; Webster MT; Huang W; Williams N; Ma Y; Cardona DM; Fan CM; Kirsch DG
    Cancer Res; 2015 Feb; 75(3):605-14. PubMed ID: 25503558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput flow cytometry screening reveals a role for junctional adhesion molecule a as a cancer stem cell maintenance factor.
    Lathia JD; Li M; Sinyuk M; Alvarado AG; Flavahan WA; Stoltz K; Rosager AM; Hale J; Hitomi M; Gallagher J; Wu Q; Martin J; Vidal JG; Nakano I; Dahlrot RH; Hansen S; McLendon RE; Sloan AE; Bao S; Hjelmeland AB; Carson CT; Naik UP; Kristensen B; Rich JN
    Cell Rep; 2014 Jan; 6(1):117-29. PubMed ID: 24373972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.
    Huang J; Chen M; Whitley MJ; Kuo HC; Xu ES; Walens A; Mowery YM; Van Mater D; Eward WC; Cardona DM; Luo L; Ma Y; Lopez OM; Nelson CE; Robinson-Hamm JN; Reddy A; Dave SS; Gersbach CA; Dodd RD; Kirsch DG
    Nat Commun; 2017 Jul; 8():15999. PubMed ID: 28691711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting glutamine metabolism improves sarcoma response to radiation therapy in vivo.
    Patel R; Cooper DE; Kadakia KT; Allen A; Duan L; Luo L; Williams NT; Liu X; Locasale JW; Kirsch DG
    Commun Biol; 2024 May; 7(1):608. PubMed ID: 38769385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.